- Asian Market Value Picks Featuring Three Stocks Estimated Below Intrinsic Value
Aug 13, 2025
In recent weeks, Asian markets have shown resilience amid global economic uncertainties, with key indices in Japan and China posting gains due to strong corporate earnings and robust trade data. As investors navigate these fluctuating conditions, identifying stocks estimated to be trading below their intrinsic value can offer potential opportunities for those seeking long-term growth.
Top 10 Undervalued Stocks Based On Cash Flows In Asia
Name Current Price Fair Value (Est) Discount (Est) Xi'an NovaStar Tech (SZSE:301589) CN¥155.66 CN¥310.49 49.9% Unimicron Technology (TWSE:3037) NT$138.50 NT$275.38 49.7% SIMMTECH (KOSDAQ:A222800) ₩27100.00 ₩53412.04 49.3% PixArt Imaging (TPEX:3227) NT$192.50 NT$377.38 49% Matsuya R&DLtd (TSE:7317) ¥714.00 ¥1427.91 50% Heartland Group Holdings (NZSE:HGH) NZ$0.80 NZ$1.58 49.5% Guangdong Lyric Robot AutomationLtd (SHSE:688499) CN¥59.00 CN¥115.97 49.1% GEM (SZSE:002340) CN¥6.68 CN¥13.10 49% Finger (KOSDAQ:A163730) ₩13170.00 ₩26259.20 49.8% Andes Technology (TWSE:6533) NT$276.00 NT$541.58 49%
Click here to see the full list of 278 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.
Let's explore several standout options from the results in the screener.
Shenzhen Envicool Technology
Overview: Shenzhen Envicool Technology Co., Ltd. specializes in producing and selling temperature control and energy-saving solutions in China, with a market cap of CN¥53.04 billion.
Operations: The company's revenue from Precision Temperature Control Energy Saving Equipment is CN¥4.78 billion.
Estimated Discount To Fair Value: 13.4%
Shenzhen Envicool Technology is trading at CN¥54.75, below its estimated fair value of CN¥63.25, presenting a potential undervaluation based on cash flows. The company's earnings are forecasted to grow 27.7% annually, outpacing the Chinese market average of 23.8%. Recent strategic alliances for data center cooling projects in ASEAN and plans for a new headquarters underscore its growth prospects despite high share price volatility over the past three months.
Our comprehensive growth report raises the possibility that Shenzhen Envicool Technology is poised for substantial financial growth. Dive into the specifics of Shenzhen Envicool Technology here with our thorough financial health report.SZSE:002837 Discounted Cash Flow as at Aug 2025
Range Intelligent Computing Technology Group
Overview: Range Intelligent Computing Technology Group Company Limited offers server hosting services to internet companies and large cloud vendors in China, with a market cap of CN¥83.16 billion.
Operations: The company's revenue from IDC Services amounts to CN¥4.58 billion.
Story Continues
Estimated Discount To Fair Value: 48.6%
Range Intelligent Computing Technology Group's stock is trading at CN¥50.88, significantly below its estimated fair value of CN¥99.01, suggesting undervaluation based on cash flows. The company forecasts a robust earnings growth rate of 28.6% annually, surpassing the Chinese market average. However, its dividend yield of 1.04% isn't well-supported by free cash flows and it carries a high level of debt while considering a second listing in Hong Kong to bolster financial flexibility.
Our earnings growth report unveils the potential for significant increases in Range Intelligent Computing Technology Group's future results. Delve into the full analysis health report here for a deeper understanding of Range Intelligent Computing Technology Group.SZSE:300442 Discounted Cash Flow as at Aug 2025
Rakus
Overview: Rakus Co., Ltd. and its subsidiaries offer cloud services in Japan, with a market cap of ¥434.14 billion.
Operations: The company's revenue is derived from its Cloud Business, generating ¥41.86 billion, and its IT Outsourcing Business, contributing ¥7.06 billion.
Estimated Discount To Fair Value: 21.4%
Rakus Co., Ltd. is trading at ¥2,408, significantly below its estimated fair value of ¥3,063.83, indicating undervaluation based on cash flows. The company anticipates a substantial earnings growth rate of 23.6% annually over the next three years, outpacing the Japanese market average. Recent sales figures show consistent performance with June 2025 sales at ¥4,782 million. While Rakus has initiated strategic share buybacks to enhance capital efficiency and shareholder returns, it also faces moderate revenue growth projections at 15.6% annually.
Upon reviewing our latest growth report, Rakus' projected financial performance appears quite optimistic. Click here and access our complete balance sheet health report to understand the dynamics of Rakus.TSE:3923 Discounted Cash Flow as at Aug 2025
Where To Now?
Embark on your investment journey to our 278 Undervalued Asian Stocks Based On Cash Flows selection here. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.
Ready For A Different Approach?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SZSE:002837 SZSE:300442 and TSE:3923.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
View Comments
- Asian Companies Estimated To Be Trading Below Intrinsic Value In August 2025
Aug 12, 2025
As global markets navigate a complex landscape marked by trade tensions and shifting monetary policies, Asian markets have shown resilience, with indices like China's CSI 300 and Japan's Nikkei 225 posting gains amid strong corporate earnings and robust export data. In this environment, identifying undervalued stocks becomes crucial for investors seeking opportunities that may offer potential value relative to their intrinsic worth.
Top 10 Undervalued Stocks Based On Cash Flows In Asia
Name Current Price Fair Value (Est) Discount (Est) Xi'an NovaStar Tech (SZSE:301589) CN¥155.66 CN¥310.49 49.9% Unimicron Technology (TWSE:3037) NT$138.50 NT$275.38 49.7% SIMMTECH (KOSDAQ:A222800) ₩27100.00 ₩53412.04 49.3% PixArt Imaging (TPEX:3227) NT$192.50 NT$377.38 49% Matsuya R&DLtd (TSE:7317) ¥714.00 ¥1427.91 50% Heartland Group Holdings (NZSE:HGH) NZ$0.80 NZ$1.58 49.5% Guangdong Lyric Robot AutomationLtd (SHSE:688499) CN¥59.00 CN¥115.97 49.1% GEM (SZSE:002340) CN¥6.68 CN¥13.10 49% Finger (KOSDAQ:A163730) ₩13170.00 ₩26259.20 49.8% Andes Technology (TWSE:6533) NT$276.00 NT$541.58 49%
Click here to see the full list of 277 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.
Let's uncover some gems from our specialized screener.
Guangdong Lyric Robot AutomationLtd
Overview: Guangdong Lyric Robot Automation Co., Ltd. (ticker: SHSE:688499) specializes in the development and manufacturing of automation equipment, with a market cap of CN¥9.88 billion.
Operations: I'm sorry, but the information provided does not include specific revenue segments for Guangdong Lyric Robot Automation Co., Ltd. If you have additional data on their revenue breakdown, I would be happy to help summarize it.
Estimated Discount To Fair Value: 49.1%
Guangdong Lyric Robot Automation Ltd. is trading at CN¥59, significantly below its estimated fair value of CN¥115.97, suggesting it may be undervalued based on cash flows. Despite recent share price volatility and substantial shareholder dilution over the past year, the company is forecast to achieve high revenue growth of 33.2% annually and become profitable within three years, outpacing average market growth in China.
Our growth report here indicates Guangdong Lyric Robot AutomationLtd may be poised for an improving outlook. Get an in-depth perspective on Guangdong Lyric Robot AutomationLtd's balance sheet by reading our health report here.SHSE:688499 Discounted Cash Flow as at Aug 2025
Recruit Holdings
Overview: Recruit Holdings Co., Ltd. offers HR technology and business solutions aimed at transforming the world of work, with a market cap of approximately ¥12.54 trillion.
Operations: The company's revenue is primarily derived from three segments: Staffing at ¥1.65 billion, HR Technology at ¥1.11 billion, and Marketing Matching Technologies at ¥825.04 million.
Story Continues
Estimated Discount To Fair Value: 28.9%
Recruit Holdings, trading at ¥8,790, appears undervalued with a fair value estimate of ¥12,363.23. Despite recent volatility and a slower revenue growth forecast of 4.5% annually compared to its past performance, the company is executing strategic buybacks worth ¥45 billion to enhance shareholder returns and fund long-term growth initiatives. Earnings are projected to grow faster than the Japanese market at 9.6% per year, supported by a robust return on equity forecast of 29.9%.
In light of our recent growth report, it seems possible that Recruit Holdings' financial performance will exceed current levels. Unlock comprehensive insights into our analysis of Recruit Holdings stock in this financial health report.TSE:6098 Discounted Cash Flow as at Aug 2025
Baycurrent
Overview: Baycurrent, Inc. offers consulting services in Japan and has a market cap of ¥1.32 billion.
Operations: The company generates revenue primarily from its Consulting Business, amounting to ¥123.32 million.
Estimated Discount To Fair Value: 16.2%
Baycurrent, trading at ¥8,710, is undervalued with a fair value estimate of ¥10,390.87. The company is experiencing robust growth with earnings projected to rise significantly over the next three years and revenue expected to grow at 20.4% annually—outpacing the Japanese market. Recent strategic buybacks totaling ¥2.99 billion indicate a focus on enhancing shareholder value amid discussions on treasury shares disposal for compensation purposes.
Upon reviewing our latest growth report, Baycurrent's projected financial performance appears quite optimistic. Click to explore a detailed breakdown of our findings in Baycurrent's balance sheet health report.TSE:6532 Discounted Cash Flow as at Aug 2025
Taking Advantage
Investigate our full lineup of 277 Undervalued Asian Stocks Based On Cash Flows right here. Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance. Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.
Contemplating Other Strategies?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SHSE:688499 TSE:6098 and TSE:6532.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
View Comments
- Asian Value Stocks Trading At Estimated Discounts Up To 44.2%
Jun 26, 2025
As global markets navigate a complex landscape marked by geopolitical tensions and fluctuating economic indicators, Asian stock markets have shown mixed performance, with some regions experiencing gains while others face challenges. Amidst this environment, identifying undervalued stocks can offer potential opportunities for investors seeking value; these stocks are often characterized by strong fundamentals and trading at prices below their intrinsic worth.
Top 10 Undervalued Stocks Based On Cash Flows In Asia
Name Current Price Fair Value (Est) Discount (Est) Wenzhou Yihua Connector (SZSE:002897) CN¥38.20 CN¥76.10 49.8% Shenzhen Techwinsemi Technology (SZSE:001309) CN¥127.30 CN¥252.61 49.6% PixArt Imaging (TPEX:3227) NT$220.00 NT$436.56 49.6% Medley (TSE:4480) ¥3160.00 ¥6255.02 49.5% Livero (TSE:9245) ¥1715.00 ¥3364.83 49% Darbond Technology (SHSE:688035) CN¥40.00 CN¥78.01 48.7% cottaLTD (TSE:3359) ¥441.00 ¥861.60 48.8% China Kings Resources GroupLtd (SHSE:603505) CN¥21.59 CN¥42.58 49.3% Bloks Group (SEHK:325) HK$139.50 HK$278.67 49.9% APAC Realty (SGX:CLN) SGD0.465 SGD0.91 48.7%
Click here to see the full list of 294 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.
Here's a peek at a few of the choices from the screener.
PharmaResearch
Overview: PharmaResearch Co., Ltd. is a biopharmaceutical company operating primarily in South Korea, with a market cap of ₩4.99 trillion.
Operations: The company's revenue is primarily derived from its pharmaceuticals segment, which generated ₩392.31 billion.
Estimated Discount To Fair Value: 30.3%
PharmaResearch is trading at ₩480,500, significantly below its estimated fair value of ₩689,851.02, highlighting its potential as an undervalued stock based on cash flows. The company forecasts robust revenue growth of 24.7% annually and earnings growth of 26.5%, outpacing the Korean market averages. Recent presentations by the CFO at global corporate events underscore a strategic focus on long-term growth initiatives within its human division and corporate restructuring efforts.
Upon reviewing our latest growth report, PharmaResearch's projected financial performance appears quite optimistic. Delve into the full analysis health report here for a deeper understanding of PharmaResearch.KOSDAQ:A214450 Discounted Cash Flow as at Jun 2025
Maxscend Microelectronics
Overview: Maxscend Microelectronics Company Limited specializes in the research, development, production, and sale of radio frequency integrated circuits in China, with a market capitalization of approximately CN¥37.90 billion.
Operations: Maxscend Microelectronics Company Limited generates its revenue primarily through the research, development, production, and sale of radio frequency integrated circuits in China.
Story Continues
Estimated Discount To Fair Value: 44.2%
Maxscend Microelectronics is trading at CNY 70.86, significantly below its estimated fair value of CNY 126.9, indicating potential undervaluation based on cash flows. Despite a challenging first quarter with a net loss of CNY 46.62 million and reduced profit margins, the company forecasts robust earnings growth of over 41% annually, surpassing the Chinese market average. Revenue is also expected to grow faster than the market at an annual rate of 18.4%.
In light of our recent growth report, it seems possible that Maxscend Microelectronics' financial performance will exceed current levels. Dive into the specifics of Maxscend Microelectronics here with our thorough financial health report.SZSE:300782 Discounted Cash Flow as at Jun 2025
Faraday Technology
Overview: Faraday Technology Corporation is a fabless ASIC/SoC and silicon IP provider operating in China, Taiwan, Japan, the United States, and internationally with a market cap of NT$48.59 billion.
Operations: The company's revenue primarily comes from its Integrated Circuit Products segment, which generated NT$15.92 billion.
Estimated Discount To Fair Value: 26%
Faraday Technology is trading significantly below its estimated fair value of NT$252.13, highlighting potential undervaluation based on cash flows. Despite a recent dip in profit margins to 7%, the company anticipates substantial earnings growth of 35.5% annually, outpacing the Taiwanese market average. Revenue is also projected to grow over 20% per year. Recent product announcements, such as the 10G SerDes IP and FlashKit-22RRAM platform, underscore Faraday's commitment to innovation and market responsiveness.
Our growth report here indicates Faraday Technology may be poised for an improving outlook. Unlock comprehensive insights into our analysis of Faraday Technology stock in this financial health report.TWSE:3035 Discounted Cash Flow as at Jun 2025
Seize The Opportunity
Access the full spectrum of 294 Undervalued Asian Stocks Based On Cash Flows by clicking on this link. Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments. Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.
Interested In Other Possibilities?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include KOSDAQ:A214450 SZSE:300782 and TWSE:3035.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
View Comments
- 3 Asian Stocks Estimated To Be Trading At Up To 48.4% Discount
Jun 25, 2025
As global markets navigate a landscape of mixed economic signals and geopolitical tensions, Asian stocks present intriguing opportunities for investors seeking value amid uncertainty. In this context, identifying undervalued stocks becomes crucial, as these equities may offer potential upside when market conditions stabilize or improve.
Top 10 Undervalued Stocks Based On Cash Flows In Asia
Name Current Price Fair Value (Est) Discount (Est) Wenzhou Yihua Connector (SZSE:002897) CN¥38.20 CN¥76.10 49.8% Shenzhen Techwinsemi Technology (SZSE:001309) CN¥127.30 CN¥252.61 49.6% PixArt Imaging (TPEX:3227) NT$220.00 NT$436.56 49.6% Medley (TSE:4480) ¥3160.00 ¥6255.02 49.5% Livero (TSE:9245) ¥1715.00 ¥3364.83 49% Darbond Technology (SHSE:688035) CN¥40.00 CN¥78.01 48.7% cottaLTD (TSE:3359) ¥441.00 ¥861.60 48.8% China Kings Resources GroupLtd (SHSE:603505) CN¥21.59 CN¥42.58 49.3% Bloks Group (SEHK:325) HK$139.50 HK$278.67 49.9% APAC Realty (SGX:CLN) SGD0.465 SGD0.91 48.7%
Click here to see the full list of 294 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.
Here we highlight a subset of our preferred stocks from the screener.
J&T Global Express
Overview: J&T Global Express Limited is an investment holding company providing integrated express delivery services across several countries including China, Indonesia, and Brazil, with a market cap of HK$61.12 billion.
Operations: The company generates revenue from its transportation services, specifically air freight, amounting to $10.26 billion.
Estimated Discount To Fair Value: 48.4%
J&T Global Express is trading at HK$6.87, significantly below its estimated fair value of HK$13.31, indicating it may be undervalued based on cash flows. The company recently became profitable and reported a substantial increase in parcel volume for Q1 2025 compared to the previous year. Despite a forecasted revenue growth of 10.6% annually, slower than some expectations, earnings are expected to grow significantly at 32.54% per year over the next three years.
Our earnings growth report unveils the potential for significant increases in J&T Global Express' future results. Get an in-depth perspective on J&T Global Express' balance sheet by reading our health report here.SEHK:1519 Discounted Cash Flow as at Jun 2025
Kotobuki Spirits
Overview: Kotobuki Spirits Co., Ltd. is a Japanese company that produces and sells sweets, with a market cap of ¥338.83 billion.
Operations: The company's revenue segments include Shukrei at ¥30.10 billion, KCC Co., Ltd. at ¥21.48 billion, Kotobuki Confectionery/Tajima Kotobuki at ¥14.55 billion, Sales Subsidiaries at ¥7.23 billion, and Kujukushima at ¥6.36 billion.
Story Continues
Estimated Discount To Fair Value: 34.5%
Kotobuki Spirits, trading at ¥2,195, is considerably below its estimated fair value of ¥3,352.98. The company's earnings are projected to grow at 9.83% annually, outpacing the Japanese market's 7%. Recent guidance anticipates net sales of ¥79.67 billion and operating profit of ¥19.65 billion for the fiscal year ending March 2026. Despite moderate revenue growth forecasts of 7.4%, Kotobuki Spirits remains undervalued based on cash flow analysis.
Insights from our recent growth report point to a promising forecast for Kotobuki Spirits' business outlook. Dive into the specifics of Kotobuki Spirits here with our thorough financial health report.TSE:2222 Discounted Cash Flow as at Jun 2025
Taiyo Yuden
Overview: Taiyo Yuden Co., Ltd. develops, manufactures, and sells electronic components in Japan, China, Hong Kong, and internationally with a market cap of ¥311.96 billion.
Operations: The company's revenue primarily comes from its Electronic Components Business, which generated ¥341.44 billion.
Estimated Discount To Fair Value: 47.5%
Taiyo Yuden is trading at ¥2,501, significantly below its estimated fair value of ¥4,762.48, indicating it is undervalued based on cash flows. Despite a volatile share price and a low profit margin of 0.7%, earnings are forecast to grow at 34.88% annually, surpassing the Japanese market's growth rate. Recent product developments in automotive inductors have driven demand higher than expected; however, foreign exchange losses have impacted profits negatively despite increased sales guidance for fiscal 2025 and 2026.
The analysis detailed in our Taiyo Yuden growth report hints at robust future financial performance. Click to explore a detailed breakdown of our findings in Taiyo Yuden's balance sheet health report.TSE:6976 Discounted Cash Flow as at Jun 2025
Taking Advantage
Explore the 294 names from our Undervalued Asian Stocks Based On Cash Flows screener here. Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports. Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.
Curious About Other Options?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SEHK:1519 TSE:2222 and TSE:6976.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
View Comments
- 3 Global Stocks Estimated To Be Up To 47.7% Below Intrinsic Value
Jun 25, 2025
Amid fluctuating global markets, with U.S. stocks showing mixed results and European indices reflecting concerns over Middle Eastern tensions, investors are navigating an environment marked by steady interest rates and economic uncertainty. In such a scenario, identifying undervalued stocks—those trading below their intrinsic value—can present opportunities for investors seeking to capitalize on potential market inefficiencies.
Top 10 Undervalued Stocks Based On Cash Flows
Name Current Price Fair Value (Est) Discount (Est) Wenzhou Yihua Connector (SZSE:002897) CN¥38.20 CN¥76.03 49.8% Shenzhen Techwinsemi Technology (SZSE:001309) CN¥127.30 CN¥251.73 49.4% Selvita (WSE:SLV) PLN28.70 PLN56.89 49.6% PixArt Imaging (TPEX:3227) NT$220.50 NT$436.57 49.5% Peijia Medical (SEHK:9996) HK$6.36 HK$12.71 49.9% Lingotes Especiales (BME:LGT) €6.00 €11.87 49.4% Galderma Group (SWX:GALD) CHF111.30 CHF221.71 49.8% Everest Medicines (SEHK:1952) HK$54.20 HK$107.07 49.4% Claranova (ENXTPA:CLA) €2.68 €5.30 49.4% Absolent Air Care Group (OM:ABSO) SEK209.00 SEK415.74 49.7%
Click here to see the full list of 498 stocks from our Undervalued Global Stocks Based On Cash Flows screener.
Let's uncover some gems from our specialized screener.
Coca-Cola Içecek Anonim Sirketi
Overview: Coca-Cola Içecek Anonim Sirketi, along with its subsidiaries, is involved in the production, sales, and distribution of both sparkling and still beverages across Turkey, Pakistan, Central Asia, and the Middle East with a market cap of TRY137.39 billion.
Operations: The company's revenue from non-alcoholic beverages amounts to TRY136.24 billion.
Estimated Discount To Fair Value: 47.6%
Coca-Cola Içecek Anonim Sirketi, trading at TRY49.1, is significantly undervalued with a fair value estimate of TRY93.72. Despite challenges like lower profit margins and interest coverage issues, its revenue growth forecast of 24.6% annually outpaces the Turkish market average. Analysts anticipate a 63.2% stock price increase, though earnings are expected to grow slower than the market at 26.5%. Recent Q1 results showed decreased net income and sales compared to last year.
The growth report we've compiled suggests that Coca-Cola Içecek Anonim Sirketi's future prospects could be on the up. Click here and access our complete balance sheet health report to understand the dynamics of Coca-Cola Içecek Anonim Sirketi.IBSE:CCOLA Discounted Cash Flow as at Jun 2025
Doosan
Overview: Doosan Corporation operates in power generation facilities, industrial facilities, construction machinery, engines, and construction sectors across Korea and internationally, with a market cap of ₩10.84 billion.
Story Continues
Operations: Doosan Corporation's revenue is derived from its operations in power generation facilities, industrial facilities, construction machinery, engines, and construction sectors across various regions including Korea, the United States, Asia, the Middle East, and Europe.
Estimated Discount To Fair Value: 43.2%
Doosan Corporation is trading at ₩672,000, significantly undervalued with a fair value estimate of ₩1,182,623.73. Recent Q1 results showed net income surged to ₩23.65 billion from the previous year's ₩4.98 billion despite slightly lower sales. Earnings are projected to grow rapidly at 69.31% annually over the next few years while revenue growth is expected to outpace the Korean market average of 4.9%. However, share price volatility remains high.
The analysis detailed in our Doosan growth report hints at robust future financial performance. Unlock comprehensive insights into our analysis of Doosan stock in this financial health report.KOSE:A000150 Discounted Cash Flow as at Jun 2025
Giant Biogene Holding
Overview: Giant Biogene Holding Co., Ltd. is an investment holding company that designs, develops, and manufactures skin treatment products featuring recombinant collagen in the People’s Republic of China, with a market cap of HK$57.06 billion.
Operations: The company's revenue primarily stems from the research, development, manufacture, and sale of bioactive material-based beauty and health products, generating CN¥5.54 billion.
Estimated Discount To Fair Value: 47.7%
Giant Biogene Holding is trading at HK$53.9, significantly below its estimated fair value of HK$103.01, suggesting substantial undervaluation based on discounted cash flow analysis. Recent earnings reported a robust increase in net income to CNY 2.06 billion from CNY 1.45 billion year-over-year, with revenue growth forecasted to outpace the Hong Kong market at 18.7% annually. The company also announced special and final dividends for shareholders, enhancing its appeal despite insider selling concerns earlier this year.
Our comprehensive growth report raises the possibility that Giant Biogene Holding is poised for substantial financial growth. Get an in-depth perspective on Giant Biogene Holding's balance sheet by reading our health report here.SEHK:2367 Discounted Cash Flow as at Jun 2025
Key Takeaways
Dive into all 498 of the Undervalued Global Stocks Based On Cash Flows we have identified here. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.
Want To Explore Some Alternatives?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include IBSE:CCOLA KOSE:A000150 and SEHK:2367.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
View Comments
- Asian Value Stocks: Uncovering 3 Companies That May Be Trading Below Fair Value Estimates
Jun 25, 2025
As China's economy grapples with mixed data and Japan's stock markets register gains, investors are increasingly looking towards Asia for potential opportunities amid global economic uncertainties. In this context, identifying undervalued stocks becomes crucial as these may offer significant growth potential when trading below their fair value estimates.
Top 10 Undervalued Stocks Based On Cash Flows In Asia
Name Current Price Fair Value (Est) Discount (Est) Shenzhen KSTAR Science and Technology (SZSE:002518) CN¥22.07 CN¥43.51 49.3% PixArt Imaging (TPEX:3227) NT$221.00 NT$436.43 49.4% Peijia Medical (SEHK:9996) HK$6.36 HK$12.71 49.9% Livero (TSE:9245) ¥1715.00 ¥3368.67 49.1% Heartland Group Holdings (NZSE:HGH) NZ$0.79 NZ$1.55 49.2% Forum Engineering (TSE:7088) ¥1187.00 ¥2368.79 49.9% Everest Medicines (SEHK:1952) HK$54.20 HK$107.07 49.4% Darbond Technology (SHSE:688035) CN¥39.73 CN¥78.08 49.1% cottaLTD (TSE:3359) ¥439.00 ¥862.26 49.1% China Kings Resources GroupLtd (SHSE:603505) CN¥21.45 CN¥42.41 49.4%
Click here to see the full list of 267 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.
We'll examine a selection from our screener results.
Gudeng Precision Industrial
Overview: Gudeng Precision Industrial Co., Ltd. offers technology services globally and has a market capitalization of NT$35.87 billion.
Operations: The company's revenue is primarily derived from semiconductor manufacturing, which accounts for NT$5.08 billion, and semiconductor equipment manufacturing, contributing NT$1.22 billion.
Estimated Discount To Fair Value: 11.4%
Gudeng Precision Industrial is trading at NT$373.5, which is 11.4% below its estimated fair value of NT$421.67, suggesting it may be undervalued based on cash flows. Despite a low forecasted return on equity of 17.7%, earnings are expected to grow significantly at 24.35% annually over the next three years, outpacing the Taiwan market's growth rate of 13.9%. However, recent dividend changes highlight potential concerns with dividend sustainability due to insufficient free cash flow coverage.
Our growth report here indicates Gudeng Precision Industrial may be poised for an improving outlook. Get an in-depth perspective on Gudeng Precision Industrial's balance sheet by reading our health report here.TPEX:3680 Discounted Cash Flow as at Jun 2025
TORIDOLL Holdings
Overview: TORIDOLL Holdings Corporation operates and manages restaurants in Japan and internationally, with a market cap of ¥362.95 billion.
Operations: The company's revenue segments include Marugame Seimen at ¥128.14 billion and the Overseas Business at ¥104.67 billion.
Estimated Discount To Fair Value: 24.5%
Story Continues
TORIDOLL Holdings, trading at ¥4,143, is valued 24.5% below its estimated fair value of ¥5,489.35 based on discounted cash flows. The company's earnings are projected to grow significantly at 43.56% annually over the next three years, surpassing the Japanese market's growth rate of 7.3%. However, profit margins have decreased from last year due to large one-off items affecting results. Recent dividend increases and future guidance reflect a cautious yet optimistic outlook amidst these challenges.
In light of our recent growth report, it seems possible that TORIDOLL Holdings' financial performance will exceed current levels. Click to explore a detailed breakdown of our findings in TORIDOLL Holdings' balance sheet health report.TSE:3397 Discounted Cash Flow as at Jun 2025
Visional
Overview: Visional, Inc., along with its subsidiaries, offers human resources platform solutions in Japan and has a market capitalization of approximately ¥432.10 billion.
Operations: The company's revenue is primarily derived from its HR Tech segment, which accounts for ¥73.55 billion, with an additional contribution of ¥2.52 billion from its Incubation segment.
Estimated Discount To Fair Value: 33.6%
Visional, Inc. is trading at ¥10,865, significantly undervalued by 33.6% against its fair value estimate of ¥16,358.67 based on discounted cash flows. Earnings have grown robustly at 36% annually over the past five years and are projected to grow 14.75% per year, outpacing the Japanese market's growth rate of 7.3%. Recent upward revisions in earnings guidance reflect strong performance in its BizReach segment and strategic investments for sustainable growth.
Insights from our recent growth report point to a promising forecast for Visional's business outlook. Click here and access our complete balance sheet health report to understand the dynamics of Visional.TSE:4194 Discounted Cash Flow as at Jun 2025
Where To Now?
Investigate our full lineup of 267 Undervalued Asian Stocks Based On Cash Flows right here. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.
Want To Explore Some Alternatives?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include TPEX:3680 TSE:3397 and TSE:4194.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
View Comments
- Asian Stocks That May Be Trading Below Estimated Value In June 2025
Jun 24, 2025
As global markets navigate a landscape marked by mixed economic signals and geopolitical tensions, Asian stock markets have shown a blend of resilience and volatility. In this environment, identifying stocks that may be trading below their estimated value can present opportunities for investors seeking to capitalize on potential market inefficiencies.
Top 10 Undervalued Stocks Based On Cash Flows In Asia
Name Current Price Fair Value (Est) Discount (Est) Shenzhen KSTAR Science and Technology (SZSE:002518) CN¥22.07 CN¥43.51 49.3% PixArt Imaging (TPEX:3227) NT$221.00 NT$436.43 49.4% Peijia Medical (SEHK:9996) HK$6.36 HK$12.71 49.9% Livero (TSE:9245) ¥1715.00 ¥3368.67 49.1% Heartland Group Holdings (NZSE:HGH) NZ$0.79 NZ$1.55 49.2% Forum Engineering (TSE:7088) ¥1187.00 ¥2368.79 49.9% Everest Medicines (SEHK:1952) HK$54.20 HK$107.07 49.4% Darbond Technology (SHSE:688035) CN¥39.73 CN¥78.08 49.1% cottaLTD (TSE:3359) ¥439.00 ¥862.26 49.1% China Kings Resources GroupLtd (SHSE:603505) CN¥21.45 CN¥42.41 49.4%
Click here to see the full list of 267 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.
Underneath we present a selection of stocks filtered out by our screen.
TaewoongLtd
Overview: Taewoong Co., Ltd specializes in manufacturing and selling open-die forgings and ring rolled products both in South Korea and internationally, with a market cap of ₩704.26 billion.
Operations: Revenue segments for KOSDAQ:A044490 include the production and distribution of open-die forgings and ring rolled products across domestic and international markets.
Estimated Discount To Fair Value: 23.6%
Taewoong Ltd. is trading at ₩35,200, significantly below its estimated fair value of ₩46,064.34, indicating it may be undervalued based on cash flows. Despite a decline in profit margins from 8.9% to 5.1%, the company's earnings are forecast to grow at a robust 39.6% annually over the next three years, outpacing both its revenue growth and the broader Korean market's earnings growth rate of 21.1%. However, share price volatility remains high recently.
Our growth report here indicates TaewoongLtd may be poised for an improving outlook. Navigate through the intricacies of TaewoongLtd with our comprehensive financial health report here.KOSDAQ:A044490 Discounted Cash Flow as at Jun 2025
Zhejiang Leapmotor Technology
Overview: Zhejiang Leapmotor Technology Co., Ltd. focuses on the research, development, production, and sale of new energy vehicles both in Mainland China and internationally, with a market cap of HK$75.61 billion.
Operations: The company's revenue primarily comes from the production, research and development, and sales of new energy vehicles, totaling CN¥32.16 billion.
Story Continues
Estimated Discount To Fair Value: 45.4%
Zhejiang Leapmotor Technology, trading at HK$56.55, is significantly below its estimated fair value of HK$103.48, highlighting potential undervaluation based on cash flows. The company's revenue is forecast to grow at 27.5% annually, surpassing the Hong Kong market's average growth rate of 8.1%. Earnings are expected to increase by 59.94% per year and become profitable within three years, indicating strong growth prospects despite recent executive changes and amendments in company bylaws.
Our earnings growth report unveils the potential for significant increases in Zhejiang Leapmotor Technology's future results. Get an in-depth perspective on Zhejiang Leapmotor Technology's balance sheet by reading our health report here.SEHK:9863 Discounted Cash Flow as at Jun 2025
Electric Connector Technology
Overview: Electric Connector Technology Co., Ltd. specializes in the research, design, development, manufacture, and sale of micro electronic connectors and interconnection system products globally, with a market cap of CN¥18.42 billion.
Operations: Electric Connector Technology Co., Ltd. generates revenue through the production and sale of micro electronic connectors and interconnection system products across various regions including China, North America, Europe, Japan, Asia Pacific, and other international markets.
Estimated Discount To Fair Value: 14.7%
Electric Connector Technology, trading at CNY 43.97, is slightly below its estimated fair value of CNY 51.52, suggesting it may be undervalued based on cash flows. Revenue and earnings are expected to grow at 22.1% and 26.12% annually, respectively, outpacing the Chinese market averages. Despite a recent dip in net income for Q1 2025 compared to last year, the company approved a dividend increase for shareholders in May 2025, reflecting confidence in future cash flows.
Our comprehensive growth report raises the possibility that Electric Connector Technology is poised for substantial financial growth. Unlock comprehensive insights into our analysis of Electric Connector Technology stock in this financial health report.SZSE:300679 Discounted Cash Flow as at Jun 2025
Turning Ideas Into Actions
Take a closer look at our Undervalued Asian Stocks Based On Cash Flows list of 267 companies by clicking here. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.
Want To Explore Some Alternatives?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include KOSDAQ:A044490 SEHK:9863 and SZSE:300679.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
View Comments
- 3 Global Stocks Estimated To Be Up To 31.5% Below Intrinsic Value
Jun 24, 2025
Amidst a backdrop of mixed performances in global markets, with U.S. stocks fluctuating due to geopolitical tensions and economic data surprises, investors are keenly observing opportunities for potential value. As central banks hold rates steady amidst elevated uncertainty, identifying undervalued stocks becomes crucial; these equities may offer significant upside if their intrinsic value is indeed higher than current market prices suggest.
Top 10 Undervalued Stocks Based On Cash Flows
Name Current Price Fair Value (Est) Discount (Est) Wenzhou Yihua Connector (SZSE:002897) CN¥37.95 CN¥75.90 50% VIGO Photonics (WSE:VGO) PLN512.00 PLN1018.87 49.7% PixArt Imaging (TPEX:3227) NT$220.50 NT$436.37 49.5% Koskisen Oyj (HLSE:KOSKI) €8.74 €17.29 49.4% J&T Global Express (SEHK:1519) HK$6.66 HK$13.28 49.8% Forum Engineering (TSE:7088) ¥1188.00 ¥2368.75 49.8% doValue (BIT:DOV) €2.252 €4.46 49.5% dormakaba Holding (SWX:DOKA) CHF706.00 CHF1397.12 49.5% Boreo Oyj (HLSE:BOREO) €14.90 €29.51 49.5% Absolent Air Care Group (OM:ABSO) SEK208.00 SEK415.73 50%
Click here to see the full list of 489 stocks from our Undervalued Global Stocks Based On Cash Flows screener.
Let's review some notable picks from our screened stocks.
Americana Restaurants International
Overview: Americana Restaurants International PLC operates a chain of restaurants across various countries in the Middle East and North Africa, with a market cap of AED17.64 billion.
Operations: The company's revenue segments include $1.69 billion from the Major Gulf Cooperation Council (GCC), $213.27 million from the Lower Gulf, and $179.10 million from North Africa.
Estimated Discount To Fair Value: 13.2%
Americana Restaurants International's stock trades at AED2.1, slightly below its fair value of AED2.42, indicating potential undervaluation based on cash flows. The company's earnings are forecast to grow 16.71% annually, outpacing the AE market's 6.3%. Recent Q1 results showed sales of US$573.38 million and net income of US$32.65 million, reflecting growth from the previous year. Analysts predict a 33.2% stock price increase, supported by high forecasted return on equity at 47.6%.
Insights from our recent growth report point to a promising forecast for Americana Restaurants International's business outlook. Unlock comprehensive insights into our analysis of Americana Restaurants International stock in this financial health report.ADX:AMR Discounted Cash Flow as at Jun 2025
Shanghai Allist Pharmaceuticals
Overview: Shanghai Allist Pharmaceuticals Co., Ltd. operates in the pharmaceutical industry and has a market cap of CN¥42.09 billion.
Operations: The company's revenue primarily comes from its Research and Development of Drugs segment, generating CN¥3.91 billion.
Story Continues
Estimated Discount To Fair Value: 31.5%
Shanghai Allist Pharmaceuticals is trading at CN¥95.65, significantly below its estimated fair value of CN¥139.56, suggesting undervaluation based on cash flows. The company reported Q1 2025 sales of CNY 1.10 billion and net income of CNY 410.5 million, showing substantial growth from the previous year. While earnings are expected to grow at 18.79% annually, this is slower than the broader Chinese market's forecasted growth rate but remains robust relative to industry peers.
Our growth report here indicates Shanghai Allist Pharmaceuticals may be poised for an improving outlook. Delve into the full analysis health report here for a deeper understanding of Shanghai Allist Pharmaceuticals.SHSE:688578 Discounted Cash Flow as at Jun 2025
Recruit Holdings
Overview: Recruit Holdings Co., Ltd. offers HR technology and business solutions aimed at transforming the world of work, with a market cap of ¥11.31 trillion.
Operations: The company generates revenue through its Staffing segment at ¥1.67 trillion, HR Technology at ¥1.13 trillion, and Matching & Solutions at ¥816.01 billion.
Estimated Discount To Fair Value: 31.4%
Recruit Holdings is trading at ¥7,910, considerably below its estimated fair value of ¥11,525.16, highlighting potential undervaluation based on cash flows. The company recently completed a significant share buyback program worth ¥449.99 billion. Analysts anticipate earnings growth of 9.3% annually—outpacing the Japanese market's 7.3%—despite recent share price volatility and slower revenue growth forecasts compared to industry standards.
In light of our recent growth report, it seems possible that Recruit Holdings' financial performance will exceed current levels. Take a closer look at Recruit Holdings' balance sheet health here in our report.TSE:6098 Discounted Cash Flow as at Jun 2025
Make It Happen
Click here to access our complete index of 489 Undervalued Global Stocks Based On Cash Flows. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.
Curious About Other Options?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ADX:AMR SHSE:688578 and TSE:6098.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
- Asian Value Stocks Estimated Below Intrinsic Worth In June 2025
Jun 19, 2025
As global markets navigate escalating geopolitical tensions and trade uncertainties, Asian stock markets have shown resilience with mixed performances across key indices. In this environment, identifying undervalued stocks can provide opportunities for investors who seek to capitalize on discrepancies between market prices and intrinsic values.
Top 10 Undervalued Stocks Based On Cash Flows In Asia
Name Current Price Fair Value (Est) Discount (Est) Wanguo Gold Group (SEHK:3939) HK$31.50 HK$62.31 49.4% Taiwan Union Technology (TPEX:6274) NT$214.50 NT$422.60 49.2% Range Intelligent Computing Technology Group (SZSE:300442) CN¥43.39 CN¥85.77 49.4% PixArt Imaging (TPEX:3227) NT$218.50 NT$435.75 49.9% Nanya New Material TechnologyLtd (SHSE:688519) CN¥39.16 CN¥77.06 49.2% M&A Research Institute Holdings (TSE:9552) ¥1292.00 ¥2554.92 49.4% Livero (TSE:9245) ¥1704.00 ¥3371.90 49.5% Global Tax Free (KOSDAQ:A204620) ₩6940.00 ₩13841.09 49.9% Ficont Industry (Beijing) (SHSE:605305) CN¥26.49 CN¥52.29 49.3% Dive (TSE:151A) ¥926.00 ¥1834.46 49.5%
Click here to see the full list of 288 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.
Let's take a closer look at a couple of our picks from the screened companies.
DAEDUCK ELECTRONICS
Overview: Daeduck Electronics Co., Ltd. is a company that supplies a range of printed circuit boards (PCB) both domestically in South Korea and internationally, with a market cap of approximately ₩859.49 billion.
Operations: The company's revenue is primarily derived from the manufacture and sale of printed circuit boards, amounting to approximately ₩892.75 million.
Estimated Discount To Fair Value: 33.3%
DAEDUCK ELECTRONICS is trading 33.3% below its estimated fair value of ₩25,543.87, with a current price of ₩17,050. Despite reporting a net loss in Q1 2025, earnings are forecast to grow significantly at 58.6% annually over the next three years, outpacing the Korean market's growth rate of 20.9%. However, it has an unstable dividend track record and a forecasted low return on equity of 8.4% in three years.
The growth report we've compiled suggests that DAEDUCK ELECTRONICS' future prospects could be on the up. Click here to discover the nuances of DAEDUCK ELECTRONICS with our detailed financial health report.KOSE:A353200 Discounted Cash Flow as at Jun 2025
Venustech Group
Overview: Venustech Group Inc. offers network security products, trusted security management platforms, and specialized security services globally, with a market cap of CN¥18.44 billion.
Operations: The company generates revenue from its Information Network Security segment, which amounts to CN¥3.01 billion.
Story Continues
Estimated Discount To Fair Value: 18.9%
Venustech Group is trading at CN¥15.32, which is 18.9% below its estimated fair value of CN¥18.9, indicating potential undervaluation based on cash flows. Despite a challenging year with decreased revenue and a net loss in 2024, the company turned profitable in Q1 2025 with CN¥1.6 million net income compared to a significant loss previously. Earnings are forecast to grow annually at 42.17%, surpassing market averages, though return on equity remains low at 3.7%.
Upon reviewing our latest growth report, Venustech Group's projected financial performance appears quite optimistic. Delve into the full analysis health report here for a deeper understanding of Venustech Group.SZSE:002439 Discounted Cash Flow as at Jun 2025
AEON FantasyLTD
Overview: AEON Fantasy Co., LTD. operates amusement facilities in Japan and has a market cap of ¥54.27 billion.
Operations: The company's revenue is derived from its operations in Japan (¥69.47 billion), ASEAN countries (¥13.18 billion), and China (¥4.83 billion).
Estimated Discount To Fair Value: 27.7%
AEON Fantasy Co., LTD. is trading at ¥2,744, significantly below its estimated fair value of ¥3,792.99, suggesting potential undervaluation based on cash flows. The company reported strong sales growth with April's operating revenue in Japan reaching ¥5.49 billion, up 10.2% year-on-year. Despite not paying a dividend last year, it plans to pay ¥15 per share this fiscal year. Earnings are projected to grow 59.29% annually and achieve profitability within three years.
Our growth report here indicates AEON FantasyLTD may be poised for an improving outlook. Unlock comprehensive insights into our analysis of AEON FantasyLTD stock in this financial health report.TSE:4343 Discounted Cash Flow as at Jun 2025
Make It Happen
Delve into our full catalog of 288 Undervalued Asian Stocks Based On Cash Flows here. Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks. Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.
Curious About Other Options?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include KOSE:A353200 SZSE:002439 and TSE:4343.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
View Comments
- Asian Stocks That Might Be Trading Below Estimated Value
Jun 17, 2025
Amid rising geopolitical tensions and trade-related concerns, Asian markets have experienced mixed performance, with some indices declining due to economic pressures, while others have shown resilience. In this environment of uncertainty, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors seeking to capitalize on market inefficiencies.
Top 10 Undervalued Stocks Based On Cash Flows In Asia
Name Current Price Fair Value (Est) Discount (Est) Taiwan Union Technology (TPEX:6274) NT$216.50 NT$424.21 49% StemCell Institute (TSE:7096) ¥1070.00 ¥2118.09 49.5% Shenzhen KSTAR Science and Technology (SZSE:002518) CN¥21.98 CN¥43.55 49.5% PixArt Imaging (TPEX:3227) NT$219.50 NT$436.51 49.7% Peijia Medical (SEHK:9996) HK$6.43 HK$12.71 49.4% Livero (TSE:9245) ¥1719.00 ¥3376.98 49.1% Good Will Instrument (TWSE:2423) NT$43.90 NT$87.32 49.7% Food & Life Companies (TSE:3563) ¥6579.00 ¥12942.09 49.2% Dive (TSE:151A) ¥917.00 ¥1832.47 50% cottaLTD (TSE:3359) ¥442.00 ¥866.08 49%
Click here to see the full list of 292 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.
We'll examine a selection from our screener results.
Celltrion
Overview: Celltrion, Inc. is a biopharmaceutical company focused on developing, producing, and selling therapeutic proteins for oncology treatments with a market cap of ₩35.78 trillion.
Operations: Celltrion generates revenue from its Biopharmaceutical segment, amounting to ₩6.18 trillion, and its Chemical Drugs segment, which contributes ₩523.71 million.
Estimated Discount To Fair Value: 15.6%
Celltrion appears undervalued based on cash flow analysis, trading at 15.6% below its estimated fair value of ₩191,807.09. Despite a modest undervaluation, the company shows promising growth prospects with earnings expected to grow significantly at 27.2% annually, outpacing the Korean market average of 21%. Recent strategic moves like share buybacks aim to enhance shareholder value while an expanded FDA designation for YUFLYMA® supports long-term revenue growth potential in biosimilars.
The analysis detailed in our Celltrion growth report hints at robust future financial performance. Click here to discover the nuances of Celltrion with our detailed financial health report.KOSE:A068270 Discounted Cash Flow as at Jun 2025
Akeso
Overview: Akeso, Inc. is a biopharmaceutical company focused on the research, development, manufacture, and commercialization of antibody drugs globally, with a market cap of HK$88.73 billion.
Operations: The company's revenue primarily comes from the research, development, production, and sale of biopharmaceutical products, totaling CN¥2.12 billion.
Story Continues
Estimated Discount To Fair Value: 28.5%
Akeso is trading at HK$98.85, well below its estimated fair value of HK$138.35, suggesting undervaluation based on cash flows. The company is poised for significant growth with earnings forecasted to increase 58.28% annually and expected profitability within three years, surpassing market averages. Recent regulatory approvals for innovative treatments like cadonilimab and ivonescimab bolster Akeso's position in oncology, potentially driving revenue growth as these therapies address critical unmet needs in cancer treatment across China and internationally.
Our earnings growth report unveils the potential for significant increases in Akeso's future results. Get an in-depth perspective on Akeso's balance sheet by reading our health report here.SEHK:9926 Discounted Cash Flow as at Jun 2025
HMT (Xiamen) New Technical Materials
Overview: HMT (Xiamen) New Technical Materials Co., Ltd. operates in the technical materials industry with a market cap of CN¥13.39 billion.
Operations: The company generates revenue from the Automobile Parts Manufacturing Industry, amounting to CN¥2.28 billion.
Estimated Discount To Fair Value: 34.5%
HMT (Xiamen) New Technical Materials is trading at CNY 40.69, significantly below its estimated fair value of CNY 62.09, indicating undervaluation based on cash flows. The company's earnings are projected to grow at 22.24% annually, outpacing the market's revenue growth rate of 12.4%. Recent developments include a private placement and share buyback program, which may enhance shareholder value despite a decrease in dividends and slower profit growth compared to the market average.
Our comprehensive growth report raises the possibility that HMT (Xiamen) New Technical Materials is poised for substantial financial growth. Navigate through the intricacies of HMT (Xiamen) New Technical Materials with our comprehensive financial health report here.SHSE:603306 Discounted Cash Flow as at Jun 2025
Where To Now?
Access the full spectrum of 292 Undervalued Asian Stocks Based On Cash Flows by clicking on this link. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.
Looking For Alternative Opportunities?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include KOSE:A068270 SEHK:9926 and SHSE:603306.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
View Comments
